BeiGene nets $750m from ADS follow-on

Pharmaceutical 230x150
By Jonathan Breen
18 Jan 2018

Chinese biopharmaceutical company BeiGene wrapped up a follow-on offering of its Nasdaq-listed American Depository Shares on Wednesday, raising a larger than expected $750m, according to a company statement.

The issuer launched the transaction after US markets closed on Tuesday, with a view to raising $650m and offering a $50m greenshoe, according to a filing with the US Securities and Exchange Commission.

But the follow-on was sealed at $750m on Wednesday (US eastern standard time), comprising ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial